IGL-200 Successfully Approved by Health Canada
May 15th, 2023 – Era Biology’s Fully Automatic Kinetic Tube Reader (IGL-200), along with its adaptation reagents Fungus (1-3)-β-D-Glucan Detection Kit...
Era Biology will host global live webinar at 19th May 2022 16:00 (UTC/GMT +08:00). The webinar will focus on early and rapid diagnostic solution for invasive fungal disease. The latest technology f...
Era Biology will host a global live webinar on November 29th 2022 22:00 (GMT +08:00). The webinar will be in Spanish. The webinar will talk about complete solutions for aspergillus galactomannan te...
Tianjin, China – March 18, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a lead and pioneer of invasive fungal disease diagnostic field since 1997...
FACIS Successfully Approved by Health Canada
We are glad to announce that the Full-Automatic Chemiluminescence Immunoassay System (FACIS), with its adaptable reagents the Aspergillus Galactomannan ...
The new subsidiary of Era Biology — Era Biology (Suzhou) Co., Ltd. recently held its grand opening ceremony.
On January 18, 2021, Gusu Yungu Industrial Park held the opening ceremony of the &...